Skip to main content
. 2021 Jul;42(7):728–734. doi: 10.15537/smj.2021.42.7.20200797

Table 3.

- Prevalence of primary mono-drug resistant tuberculosis

Mono-drug resistant 2000 - 2002 2003 - 2005 2006 - 2008 2009 - 2011 2012 - 2014 2015 - 2018 Total n (%)
Ethambutol 5 3 3 3 1 6 21 (7.1)
Isoniazid 6 3 21 25 8 16 79 (26.7)
Pyrazinamide 0 4 27 32 16 20 99 (33.4)
Rifampicin 3 15 4 3 0 11 36 (12.2)
Streptomycin 4 5 18 18 0 16 61 (20.6)
Total 18 30 73 81 25 69 296 (100)